Ralaniten triacetate
Ralaniten triacetate (EPI-506) is an orally bioavailable, first-in-class inhibitor targeting the androgen receptor N-terminal domain. It demonstrates anticancer activity and is a valuable research tool for investigating prostate and breast cancer in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1637573-04-6
Product Name Alternative
AndrogenReceptor, Androgen Receptor, EPI-506, Ralaniten
Field of Research
Metabolism Research
Purity
98.69% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:3.3 mg/mL (6.33 mM) ; DMSO:80 mg/mL (153.55 mM)
Smiles
CC (=O) OC[C@H] (COc1ccc (cc1) C (C) (C) c1ccc (OC[C@@H] (CCl) OC (C) =O) cc1) OC (C) =O
Molecular Formula
C27H33ClO8
Molecular Weight
521.00
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
133105-FITC 100 µL
Semaphorin 4D (Semaphorin-4D, SEMA4D, A8, BB18, C9orf164, CD100, coll-4, GR3, M-sema-G, SEMAJ) (FITC)
Sign In for Pricing
View Details LV797596 1.0 µg DNA
FAM189A1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details